Tech giants are racing to throw their hats into the mix of new AI chatbots that will vie to compete…
McAlinden Research PartnersFebruary 7, 2023
Bitcoin Mining is Back to Profitability, Hash Ribbon Shows Peak Capitulation May Have Finally Passed
Bitcoin's (BTC) strong rebound throughout the past month has helped to dig miners out of the negative profit margins many…
McAlinden Research PartnersJanuary 24, 2023
Top US banks have reported a largely mixed set of earnings for Q4 2022. However, some of the most recent…
McAlinden Research PartnersJanuary 19, 2023
The biopharma industry is kicking off the year with price hikes and some early signs of a sustained uptick in…
McAlinden Research PartnersJanuary 5, 2023
TikTok is back in the crosshairs of the US government after an initial effort to ban the massive social media service fell…
McAlinden Research PartnersDecember 14, 2022
Cannabis stocks plummeted yesterday after measures that would have helped the industry access banking infrastructure were excluded from the US's…
McAlinden Research PartnersDecember 7, 2022
Three pharma giants are in the running to purchase Horizon Therapeutics in what will likely be a larger deal than…
McAlinden Research PartnersDecember 1, 2022
Stocks remain far off from their 2021 high, but it’s not exactly correct to call them “cheap”. Multiples like the…
McAlinden Research PartnersNovember 22, 2022
Successful approval of Proposition 122 in Colorado made it the second state in the US to decriminalize hallucinogenic mushrooms like psilocybin. Clinics…
McAlinden Research PartnersNovember 17, 2022
